Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 11/54
Mary
Landrieu
U.S. Senate · D-LA
Taken from pharma & insurers
$118,181
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 11/54
Pharma & Health$108,931
Insurers & HMOs$9,250
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 11 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$118,181
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
After office
We checked the public record. No industry job, board seat, or gift after this vote.
Sometimes the vote really is free.
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$108,931
Johnson & Johnson$87,431
Bristol Myers Squibb$7,450
PhRMA$6,500
Pfizer$2,800
Merck$1,750
Eli Lilly$1,000
AbbVie$1,000
Amgen$1,000
Insurers & HMOs$9,250
AHIP$7,000
UnitedHealth$1,000
Humana$750
Aetna$500